Rhodiola rosea in DrugAge

Summary

SpeciesAssaysAvg Lifespan Change (%)Maximum Lifespan Change (%)
Drosophila melanogaster1016.7 6.6
Bombyx mori22.7 2.7
Summary Total Assays: 12 Max: 16.7 Max: 6.6

Results for Rhodiola rosea

Species Avg Lifespan change (%) Max Lifespan change (%) Strain Dosage Gender Significance

Selected Lifespan Change:

Species Avg Lifespan change (%) Max Lifespan change (%) Strain Dosage Gender Significance Reference

References

Primary References
Jafari, M et al. (2007) Rhodiola: a promising anti-aging Chinese herb. Rejuvenation Res 10(4)587-602 PubMed
Gospodaryov, DV et al. (2013) Lifespan extension and delay of age-related functional decline caused by Rhodiola rosea depends on dietary macronutrient balance. Longev Healthspan 2(1)5 PubMed
Chen, C et al. (2016) Rhodiola rosea extends lifespan and improves stress tolerance in silkworm, Bombyx mori. Biogerontology 17(2)373-381 PubMed

DGIdb human gene-drug interactions for Rhodiola rosea

Entrez Gene Symbol Gene Name Interaction Source Interaction Type GenAge Interactions

Stitch DB human protein-drug interactions for Rhodiola rosea

The data below is based on a Stitch DB API call for human protein-drug interactions for Rhodiola rosea

Up to 20 direct protein and drug interactions are displayed, having a medium confidence score (0.450) or above.

Rhodiola rosea

Displayed below are the associated biological networks for each of the top 20 direct Rhodiola rosea protein interactors.

Ensembl Id StringDB Id